Sign inGet started

Eichenfield Lawrence

Insider CIK 1814892 · FBRX Director · VRCA Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
VRCA Verrica Pharmaceuticals In A Award deriv2026-06-052026-06-0916,000— $016,000SEC↗
VRCA Verrica Pharmaceuticals In A Award deriv2025-06-052025-06-0920,000— $020,000SEC↗
FBRX Forte Biosciences, Inc. A Award deriv2024-08-202024-08-2250,000— $050,000SEC↗
VRCA Verrica Pharmaceuticals In A Award deriv2024-06-062024-06-0720,000— $020,000SEC↗
FBRX Forte Biosciences, Inc. A Award deriv2023-09-192023-09-2025,000— $025,000SEC↗
VRCA Verrica Pharmaceuticals In A Award deriv2023-06-082023-06-1210,384— $010,384SEC↗
VRCA Verrica Pharmaceuticals In A Award deriv2022-06-092022-06-1310,384— $010,384SEC↗
FBRX Forte Biosciences, Inc. A Award deriv2022-06-012022-06-0225,000— $025,000SEC↗
FBRX Forte Biosciences, Inc. A Award deriv2022-02-232022-02-2425,000— $025,000SEC↗
VRCA Verrica Pharmaceuticals In A Award deriv2021-06-102021-06-145,834— $05,834SEC↗
VRCA Verrica Pharmaceuticals In A Award deriv2021-06-102021-06-178,109— $08,109SEC↗
FBRX Forte Biosciences, Inc. A Award deriv2021-05-282021-06-0120,000— $020,000SEC↗
VRCA Verrica Pharmaceuticals In A Award deriv2020-08-012020-08-0317,502— $017,502SEC↗
FBRX Forte Biosciences, Inc. A Award deriv2020-06-152020-06-1730,000— $030,000SEC↗